Direct-to-Consumer Marketing of High-Technology Screening Tests
- 14 February 2002
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 346 (7), 529-531
- https://doi.org/10.1056/nejm200202143460715
Abstract
The authors sharply criticize the now-common practice of marketing high-technology medical screening tests directly to the consumer. As a prominent example, they select electron-beam computed tomography to screen for lung cancer. The authors voice concern about the validity of such screening, the financial consequences, and potential ethical problems.Keywords
This publication has 12 references indexed in Scilit:
- Direct-to-Consumer Advertising — Strengthening Our Health Care SystemNew England Journal of Medicine, 2002
- Annals of Internal MedicinePublished by American Medical Association (AMA) ,2001
- Screening for Lung CancerNew England Journal of Medicine, 2000
- Lung Cancer Mortality in the Mayo Lung Project: Impact of Extended Follow-upJNCI Journal of the National Cancer Institute, 2000
- American College of Cardiology/American Heart Association Expert Consensus Document on Electron-Beam Computed Tomography for the Diagnosis and Prognosis of Coronary Artery DiseaseCirculation, 2000
- Correlation of Tumor Size and Survival in Patients With Stage IA Non-small Cell Lung CancerChest, 2000
- Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations11The views contained herein represent the private views of the authors and should not be construed in any way to represent those of the Department of Defense or the Department of the Army.The American Journal of Cardiology, 2000
- Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 1999
- Coronary Calcium Does Not Accurately Predict Near-Term Future Coronary Events in High-Risk AdultsCirculation, 1999
- What Is Left of Professionalism after Managed Care?The Hastings Center Report, 1999